ESC 365 - Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials

Open Access

Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials

Session: Amyloid and acute heart failure therapy advances

Topic: Pharmacotherapy

Speaker: Doctor D. Rodolico (Pisa, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Daniele Rodolico

University of Pisa, Pisa (Italy)

1 follower

6 more presentations in this session

Pillars of heart failure therapy: improving LV function in conventional cardiac pacing

Speaker: Assistant Professor L. Cirin (Timisoara, RO)

SGLT2 inhibitor use in underweight patients with diabetes mellitus and heart failure

Speaker: Doctor Y. Fujimoto (Tokyo, JP)

Pre- and post- discharge implementation of medical therapy in patients hospitalized due to acute heart failure: a multinational observational registry

Speaker: Doctor M. Manzoni (Brescia, IT)

Risk of all-cause mortality and heart failure hospitalizations in patients treated with vericiguat in real world settings

Speaker: Doctor F. Kerwagen (Wuerzburg, DE)

Impact of Tafamidis on clinical outcomes in real-world patients with ATTR-CM

Speaker: Doctor I. Araujo (Lisbon, PT)

Access the full session

Amyloid and acute heart failure therapy advances

Speakers: Doctor D. Rodolico, Assistant Professor L. Cirin, Doctor Y. Fujimoto, Doctor M. Manzoni, Doctor F. Kerwagen...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources